Medical Observer - Information is our Prescription

About Us      Contact Us      Our Services      Press Room      Careers

 

Front-page

Heard and Read

In the News

Features

Genetics

NIH Forum

Cancer Watch

New Frontiers

UN Health

Tech Med

Drug Updates

Industry News

Off Duty

 

CME Calendar

Local
Conventions

Overseas
Conventions

powered by: FreeFind

November - December 2007

October 2007

More Issues
Medical Tourism Asia

Mailing List
Receive updates from Medical Observer

Name
Email
Specialty
PRC Lic.

 
 
 
 
 

Oncology

Targeting EGFR Shown Effective

British medical oncologist Michael Cullen talks about the role of targeting the epidermal growth factor receptor in managing nonsmall cell lung cancer.

More on this Story

Power Over Breast Cancer

Letrozole seen as alternative to gold standard tamoxifen, says noted oncologist.

More on this Story 

Starving Breast Tumors to Death

Exemestane's mechanism of action proves superior for second-line breast cancer therapy.  

More on this Story

Tailor Treament to the Patient

Dr. Matti Aapro of Switzerland's Clinique de Genolier-Institut Multidisciplinaire d'Oncologie talks about the benefits of the taxane taxotere to the treatment of nonsmall cell lung cancer.  

More on this Story

 

Updated last February 14, 2008 , Developed and Maintained by JML Internet Solutions
Best viewed with Microsoft Internet Explorer 5 and up at 800x600 resolution

Notice: The articles in this website are meant for information and education purposes only and are not intended to encourage self-diagnosis and self-medication. Readers should consult their physicians for professional medical advice. 

Copyright © 2006, Medical Observer. All rights reserved.